Cardiovascular Risk
Also known as: Cardiovascular Risk Markers / Cardiovascular Risks Markers / Cardiovasculars Risk Factors / Cardiovascular Disease Risk / Cardiovascular Disease (CVD) Risk Factors / Cardiovascular Risks / Cardiovascular Diseases Risk / Risk Factor, Cardiovascular / Cardiovascular Disease Risk Factors / Cardiovascular (CV) Risk / Cardiovascular Factor Risk / Cardiovascular Disease Risk Factor / Risk Factors Cardiovascular Disease / Cardiovascular Risk Factor / Cardiovascular Risk Factors / CVD Risk Factors / Disease risk factor
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00945 | Acetylsalicylic acid | A salicylate used to treat pain, fever, inflammation, migraines, and reducing the risk of major adverse cardiovascular events. |
| DB01076 | Atorvastatin | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. |
| DB06292 | Dapagliflozin | A sodium-glucose cotransporter 2 inhibitor used in the management of type 2 diabetes mellitus. |
| DB09045 | Dulaglutide | A GLP-1 agonist used to manage type 2 diabetes mellitus. |
| DB08887 | Icosapent ethyl | An ethyl ester of eicosapentaenoic acid (EPA) that reduces synthesis and enhances clearance of triglycerides that is used to treat patients with severe hypertriglyceridemia. |
| DB00331 | Metformin | A biguanide antihyperglycemic used in conjunction with diet and exercise for glycemic control in type 2 diabetes mellitus. It is also used off-label for insulin resistance in polycystic ovary syndrome (PCOS). |
| DB12713 | Sotagliflozin | An orally administered dual SGLT1/2 inhibitor used alongside insulin to improve glycemic control in patients with type 1 diabetes mellitus. |